Edition:
India

Xvivo Perfusion AB (XVIVO.ST)

XVIVO.ST on Stockholm Stock Exchange

91.00SEK
19 Jan 2018
Change (% chg)

-0.60kr (-0.66%)
Prev Close
91.60kr
Open
92.30kr
Day's High
93.00kr
Day's Low
89.50kr
Volume
24,105
Avg. Vol
19,812
52-wk High
108.00kr
52-wk Low
78.25kr

Latest Key Developments (Source: Significant Developments)

Xvivo Q3 EBITDA ex-items at SEK 4.4 million
Friday, 27 Oct 2017 

Oct 27 (Reuters) - XVIVO PERFUSION AB ::Q3 NET SALES SEK ‍32.3​ MILLION VERSUS SEK 31.7 MILLION YEAR AGO.Q3 EBITDA EX-ITEMS SEK ‍4.4​ MILLION VERSUS SEK 5.4 MILLION YEAR AGO.  Full Article

XVIVO Perfusion plans private placement
Friday, 17 Mar 2017 

Xvivio Pwerfusion AB : Announced on Thursday its intention to undertake a private placement of shares . Said intends to offer up to 2,361,408 new shares . The subscription price for the shares in the private placement will be determined in the book building process .Said reason behing private placement is to broaden the shareholder base, said directed share issue means lower costs and faster process.  Full Article

Xvivo Perfusion Q2 EBITDA ex-items up at SEK 6.9 million
Friday, 15 Jul 2016 

Xvivo Perfusion AB : Q2 net sales 34.5 million Swedish crowns ($4.1 million) versus 29.1 million crowns year ago . Q2 EBITDA ex-items 6.9 million crowns versus 4.6 million crowns year ago . Says focus during 2016 is therefore to establish STEEN Solution method as the standard treatment for lung transplantation .Since acquisition of Vivoline company will intensify research and development in cardiac transplantation.  Full Article

Xvivo Perfusion: share warrant program fully subscribed
Friday, 8 Jul 2016 

Xvivo Perfusion AB :Upon full exercise of warrants, share capital increase is around 5,500 Swedish crowns ($650) corresponding to a dilution of about 0.9 percent of total number of shares and votes.  Full Article

XVIVO Perfusion extends acceptance period for public offer on Vivoline Medical
Tuesday, 21 Jun 2016 

Xvivo Perfusion AB : Extends acceptance period for public offer on Vivoline Medical . Acceptance period is being extended until and including July 14, 2016 .Final payments of consideration are estimated to be made around July 20, 2016.  Full Article

Xvivo Perfusion: XPS contract signed with leading hospital in Alabama, USA
Friday, 17 Jun 2016 

Xvivo Perfusion AB : XPS contract signed with leading hospital in Alabama . XPS is the first sold to Alabama, USA .Delivery and installation of XPS will take place in July 2016.  Full Article

Xvivo Perfusion makes recommended public bid for Vivoline Medical
Monday, 18 Apr 2016 

Xvivo Perfusion AB:Announces recommended public offer to holders of shares in Vivoline Medical.Offers for every share in Vivoline Medical 1.2921 Swedish crown in cash and 0.1543 shares in Xvivo Perfusion.The consideration corresponds to a value of about 9.32 Swedish crowns per share.Says the total value of the offer amounts to about 128.5 million Swedish crowns.Cash part of the offer is fully funded by Xvivo Perfusion's own current liquid funds.  Full Article

Xvivo Perfusion to deliver XPS to hospital in Boston, US
Friday, 15 Apr 2016 

Xvivo Perfusion AB:Signs contract with a hospital in Boston, the United States.Delivery and installation of the XPS is estimated to take place early May 2016.  Full Article

Xvivo says XPS to be delivered to the first clinic in France
Wednesday, 24 Feb 2016 

Xvivo Perfusion AB:Says Hôpital FOCH in Paris is the first clinic in France that has decided to use XPS.Delivery and installation is estimated to take place at end of March 2016​.  Full Article

Xvivo Perfusion AB admitted to trading on Nasdaq First North Premier
Friday, 5 Feb 2016 

Xvivo Perfusion AB:Xvivo Perfusion admitted to trading on Nasdaq First North Premier.First day of trading in Xvivo Perfusion's shares on Nasdaq First North Premier will be Feb. 8, 2016.  Full Article

BRIEF-Xvivo Q3 EBITDA ex-items at SEK 4.4 million

* Q3 NET SALES SEK ‍32.3​ MILLION VERSUS SEK 31.7 MILLION YEAR AGO